rich 1.0 Watch on YouTube (https://www.youtube.com/watch?v=N9YB9keYPXQ) MedPal AI Plc (AIM: MPAL) (https://www.voxmarkets.com/listings/MPAL:LN)   has snapped up the Remedi pharmacy assets out of administration for less than half a million pounds — a deal that brings with it an NHS dispensing hub in Runcorn, a care home patient book that historically delivered over £10 million in annualised turnover, and a fleet of BD Rowa robotic dispensing kit. Founder and CEO Jason Drummond joins us to unpack the numbers, explain how the Swaffham reactivation playbook will be re-run at scale across the new patient book, and lay out the path to pharmacy-level EBITDA breakeven at 80,000 items a month — pencilled in for October or November this year. We get into the strategic logic of a north-south footprint, where the execution risks sit, and how today’s deal fits into the bigger MedPal story across MedPal.clinic, Health OS and the at-home blood test business. The Vox Markets Podcast https://audioboom.com/channels/5051662-the-vox-markets-podcast Audioboom https://audioboom.com 480 95 https://audioboom.com/i/40555564/600x600/c 600 600 <iframe width="100%" height="95" src="https://embeds.audioboom.com/posts/8896856/embed?v=202301" style="background-color: transparent; display: block; padding: 0; width: 100%" frameborder="0" allowtransparency="allowtransparency" scrolling="no" title="Audioboom player" allow="autoplay" sandbox="allow-downloads allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>